> On Feb 19, 4:45 pm, "brainyblog...@gmail.com"
>
[quoted text clipped - 31 lines]
> I'm betting that very few people have tried this, but it's something
> for our ADT folks to think about if or when ADT stops working.
Sirs:
Revlimid is a new version of Thalidomide, the dreaded drug from the
1960's. It is indeed an anti-angiogenesis drug. It is advertised to
have fewer of the side effects of thalidomide. The good news is that
it is associated with effectiveness in treating solid tumors, such as
prostate cancer, alone or particularly in concert with other drugs.
See the spectacular results of Ning, et. al, with Avastin+Thalidomide
+Docetaxel for metastatic PCa. The bad news about Revlimid is that it
is very expensive; 5,000$-8,000$ per month for daily treatment. So
says my local oncologist.
DominicM - 21 Feb 2008 23:00 GMT
> > On Feb 19, 4:45 pm, "brainyblog...@gmail.com"
>
[quoted text clipped - 44 lines]
>
> - Show quoted text -
When I met for one of my 2nd opinions with Johns Hopkins the Med Onc
was suggesting a Revlamed trial however I believe the one at Hopkins
is closed.
DominicM - 01 Mar 2008 14:04 GMT
> > > On Feb 19, 4:45 pm, "brainyblog...@gmail.com"
>
[quoted text clipped - 50 lines]
>
> - Show quoted text -
Correction. I just heard from Johns Hopkins and their Revlamed trial
is open.